Agency Forms Undergoing Paperwork Reduction Act Review, 78969-78971 [2022-28004]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–8833; Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–28000 Filed 12–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–23–0666]
TKELLEY on DSK125TN23PROD with NOTICE
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National
Healthcare Safety Network (NHSN)’’ to
the Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on August 26, 2022 to obtain
comments from the public and affected
agencies. CDC received one comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB Control No. 0920–0666,
Exp. 1/31/2025)—Revision—National
Center for Emerging and Zoonotic
Infection Diseases (NCEZID), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC) collects
data from healthcare facilities in the
National Healthcare Safety Network
(NHSN) under OMB Control No. 0920–
0666. NHSN provides facilities, states,
regions, and the nation with data
necessary to identify problem areas,
measure the progress of prevention
efforts, and ultimately eliminate
healthcare-associated infections (HAIs)
nationwide. NHSN allows healthcare
facilities to track blood safety errors and
various healthcare-associated infection
prevention practice methods such as
healthcare personnel influenza vaccine
status and corresponding infection
control adherence rates.
NHSN currently has seven
components: Patient Safety (PS);
Healthcare Personnel Safety (HPS);
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
78969
Biovigilance (BV); Long-Term Care
Facility (LTCF); Outpatient Procedure
(OPC); Dialysis Component; and the
Neonatal Component. NHSN has
increasingly served as the operating
system for HAI reporting compliance
through legislation established by the
states. As of April 2020, 36 states, the
District of Columbia and the City of
Philadelphia, Pennsylvania have opted
to use NHSN as their primary system for
mandated reporting. Reporting
compliance is completed by healthcare
facilities in their respective
jurisdictions, with emphasis on those
states and municipalities acquiring
varying consequences for failure to use
NHSN. Additionally, healthcare
facilities in five U.S. territories (Puerto
Rico, American Samoa, the U.S. Virgin
Islands, Guam, and the Northern
Mariana Islands) are voluntarily
reporting to NHSN. Additional
territories are projected to follow with
similar use of NHSN for reporting
purposes. NHSN’s data is used to aid in
the tracking of HAIs and guide infection
prevention activities/practices that
protect patients. The Centers for
Medicare and Medicaid Services
(CMS)and other payers use these data to
determine incentives for performance at
healthcare facilities across the US and
surrounding territories, and members of
the public may use some protected data
to inform their selection among
available providers. Each of these
parties is dependent on the
completeness and accuracy of the data.
CDC and CMS work closely and are
fully committed to ensuring complete
and accurate reporting, which are
critical for protecting patients and
guiding national, state, and local
prevention priorities.
CMS collects some HAI data and
healthcare personnel influenza
vaccination summary data, which is
done on a voluntary basis as part of its
Fee-for-Service Medicare quality
reporting programs, while others may
report data required by a federal
mandate. Facilities that fail to report
quality measure data are subject to
partial payment reduction in the
applicable Medicare Fee-for-Service
payment system. CMS links their
quality reporting to payment for
Medicare-eligible acute care hospitals,
inpatient rehabilitation facilities, longterm acute care facilities, oncology
hospitals, inpatient psychiatric
facilities, dialysis facilities, and
ambulatory surgery centers. Facilities
report HAI data and healthcare
personnel influenza vaccination
summary data to CMS via NHSN as part
of CMS’s quality reporting programs to
E:\FR\FM\23DEN1.SGM
23DEN1
78970
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
receive full payment. Still, many
healthcare facilities, even in states
without HAI reporting legislation,
submit limited HAI data to NHSN
voluntarily. NHSN’s data collection
updates continue to support the
incentive programs managed by CMS.
For example, survey questions support
requirements for CMS’ quality reporting
programs. Additionally, CDC has
collaborated with CMS on a voluntary
National Nursing Home Quality
Collaborative, which focuses on
recruiting nursing homes to report HAI
data to NHSN and to retain their
continued participation.
The NHSN collection was previously
approved in January of 2022 for
1,321,991 burden hours. The proposed
changes to NHSN include revisions to
41 existing data collection forms. CDC
requests OMB approval for an estimated
1,614,651 annual burden hours.
TKELLEY on DSK125TN23PROD with NOTICE
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form No. & name
NHSN Participant ...
57.100 NHSN Registration Form ............................................................
57.101 Facility Contact Information ........................................................
57.103 Patient Safety Component—Annual Hospital Survey ................
57.104 Facility Administrator Change Request Form .............................
57.105 Group Contact Information .........................................................
57.106 Patient Safety Monthly Reporting Plan .......................................
57.108 Primary Bloodstream Infection (BSI) ..........................................
57.111 Pneumonia (PNEU) ....................................................................
57.112 Ventilator-Associated Event ........................................................
57.113 Pediatric Ventilator-Associated Event (PedVAE) .......................
57.114 Urinary Tract Infection (UTI) .......................................................
57.115 Custom Event .............................................................................
57.116 Denominators for Neonatal Intensive Care Unit (NICU) ............
57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC)
57.118 Denominators for Intensive Care Unit (ICU)/Other locations
(not NICU or SCA).
57.120 Surgical Site Infection (SSI) ........................................................
57.121 Denominator for Procedure ........................................................
57.122 HAI Progress Report State Health Department Survey .............
57.123 Antimicrobial Use and Resistance (AUR)-Microbiology Data
Electronic Upload Specification Tables.
57.124 Antimicrobial Use and Resistance (AUR)-Pharmacy Data Electronic Upload Specification Tables.
57.125 Central Line Insertion Practices Adherence Monitoring .............
57.126 MDRO or CDI Infection Form .....................................................
57.127 MDRO and CDI Prevention Process and Outcome Measures
Monthly Monitoring.
57.128 Laboratory-identified MDRO or CDI Event .................................
57.129 Adult Sepsis ................................................................................
57.135 Late Onset Sepsis/Meningitis Denominator Form: Data Table
for monthly electronic upload.
57.136 Late Onset Sepsis/Meningitis Event Form: Data Table for
Monthly Electronic Upload.
57.137 Long-Term Care Facility Component—Annual Facility Survey ..
57.138 Laboratory-identified MDRO or CDI Event for LTCF .................
57.139 MDRO and CDI Prevention Process Measures Monthly Monitoring for LTCF.
57.140 Urinary Tract Infection (UTI) for LTCF .......................................
57.141 Monthly Reporting Plan for LTCF ...............................................
57.142 Denominators for LTCF Locations ..............................................
57.143 Prevention Process Measures Monthly Monitoring for LTCF ....
57.150 LTAC Annual Survey ..................................................................
57.151 Rehab Annual Survey .................................................................
57.200 Healthcare Personnel Safety Component Annual Facility Survey.
57.204 Healthcare Worker Demographic Data .......................................
57.205 Exposure to Blood/Body Fluids ..................................................
57.206 Healthcare Worker Prophylaxis/Treatment .................................
57.207 Follow-Up Laboratory Testing .....................................................
57.210 Healthcare Worker Prophylaxis/Treatment-Influenza .................
57.300 Hemovigilance Module Annual Survey .......................................
57.301 Hemovigilance Module Monthly Reporting Plan .........................
57.303 Hemovigilance Module Monthly Reporting Denominators .........
57.305 Hemovigilance Incident ...............................................................
57.306 Hemovigilance Module Annual Survey—Non-acute care facility
57.307 Hemovigilance Adverse Reaction—Acute Hemolytic Transfusion Reaction.
57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction.
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
(in hours)
Average
burden per
response
(in hours)
2,000
2,000
6765
800
1,000
7,821
5,775
1,800
5,463
334
6,000
600
1,100
500
5,500
1
1
1
1
1
12
5
2
8
1
5
91
12
12
60
5/60
10/60
90/60
5/60
5/60
15/60
38/60
30/60
28/60
30/60
20/60
35/60
4/60
5/60
5/60
6,000
6,000
55
2,500
9
602
1
12
35/60
10/60
28/60
5/60
2,500
12
5/60
500
720
5,500
213
11
29
25/60
30/60
15/60
4,800
50
300
79
250
6
20/60
25/60
5/60
300
6
5/60
17,700
1998
1998
1
24
12
120/60
20/60
20/60
339
2011
339
130
620
1,340
50
36
12
12
12
1
1
1
35/60
5/60
35/60
5/60
82/60
82/60
480/60
50
50
50
50
50
500
500
500
500
500
500
200
50
30
50
50
1
12
12
10
1
4
20/60
60/60
15/60
15/60
10/60
85/60
60/60
70/60
10/60
35/60
20/60
500
4
20/60
E:\FR\FM\23DEN1.SGM
23DEN1
78971
Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
respondents
Form No. & name
57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction.
57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction.
57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic
Transfusion Reaction.
57.312 Hemovigilance Adverse Reaction—Hypotensive Transfusion
Reaction.
57.313 Hemovigilance Adverse Reaction—Infection ..............................
57.314 Hemovigilance Adverse Reaction—Post Transfusion Purpura ..
57.315 Hemovigilance Adverse Reaction—Transfusion Associated
Dyspnea.
57.316 Hemovigilance Adverse Reaction—Transfusion Associated
Graft vs. Host Disease.
57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute
Lung Injury.
57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload.
57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction.
57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction
57.400 Outpatient Procedure Component—Annual Facility Survey ......
57.401 Outpatient Procedure Component—Monthly Reporting Plan .....
57.402 Outpatient Procedure Component Same Day Outcome Measures.
57.403 Outpatient Procedure Component—Monthly Denominators for
Same Day Outcome Measures.
57.404 Outpatient Procedure Component—SSI Denominator ...............
57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ..
57.500 Outpatient Dialysis Center Practices Survey ..............................
57.501 Dialysis Monthly Reporting Plan .................................................
57.502 Dialysis Event .............................................................................
57.503 Denominator for Outpatient Dialysis ...........................................
57.504 Prevention Process Measures Monthly Monitoring for Dialysis
57.505 Dialysis Patient Influenza Vaccination ........................................
57.506 Dialysis Patient Influenza Vaccination Denominator ..................
57.507 Home Dialysis Center Practices Survey .....................................
Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Non-Long-Term Care Facilities.
Weekly Healthcare Personnel Influenza Vaccination Cumulative Summary for Long-Term Care Facilities.
Weekly Resident Influenza Vaccination Cumulative Summary for
Long-Term Care Facilities.
Annual Healthcare Personnel Influenza Vaccination Summary .............
Monthly Survey Patient Days & Nurse Staffing ......................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–28004 Filed 12–22–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–23–1318]
TKELLEY on DSK125TN23PROD with NOTICE
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Requirement
for Proof of COVID–19 Vaccination for
Noncitizen, Nonimmigrant Air
Passengers Arriving into the United
States from a Foreign Country’’ to the
VerDate Sep<11>2014
20:36 Dec 22, 2022
Jkt 259001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
(in hours)
Average
burden per
response
(in hours)
500
1
20/60
500
2
20/60
500
4
20/60
500
1
20/60
500
500
500
1
1
1
20/60
20/60
20/60
500
1
20/60
500
1
20/60
500
2
20/60
500
1
20/60
500
700
700
200
1
1
12
1
20/60
10/60
15/60
40/60
200
400
40/60
700
700
7,200
7,200
7,200
7,200
1,730
615
615
430
125
100
5
1
12
30
30
12
50
5
1
52
40/60
40/60
12/60
5/60
25/60
10/60
75/60
10/60
10/60
30/60
60/60
1,200
52
60/60
2,500
52
60/60
5,000
2,500
1
12
120/60
60/60
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on July 5, 2022 to obtain
comments from the public and affected
agencies. CDC received 5,935 comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 87, Number 246 (Friday, December 23, 2022)]
[Notices]
[Pages 78969-78971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28004]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-23-0666]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Healthcare Safety Network (NHSN)''
to the Office of Management and Budget (OMB) for review and approval.
CDC previously published a ``Proposed Data Collection Submitted for
Public Comment and Recommendations'' notice on August 26, 2022 to
obtain comments from the public and affected agencies. CDC received one
comment related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Healthcare Safety Network (NHSN) (OMB Control No. 0920-
0666, Exp. 1/31/2025)--Revision--National Center for Emerging and
Zoonotic Infection Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention (CDC) collects data from healthcare
facilities in the National Healthcare Safety Network (NHSN) under OMB
Control No. 0920-0666. NHSN provides facilities, states, regions, and
the nation with data necessary to identify problem areas, measure the
progress of prevention efforts, and ultimately eliminate healthcare-
associated infections (HAIs) nationwide. NHSN allows healthcare
facilities to track blood safety errors and various healthcare-
associated infection prevention practice methods such as healthcare
personnel influenza vaccine status and corresponding infection control
adherence rates.
NHSN currently has seven components: Patient Safety (PS);
Healthcare Personnel Safety (HPS); Biovigilance (BV); Long-Term Care
Facility (LTCF); Outpatient Procedure (OPC); Dialysis Component; and
the Neonatal Component. NHSN has increasingly served as the operating
system for HAI reporting compliance through legislation established by
the states. As of April 2020, 36 states, the District of Columbia and
the City of Philadelphia, Pennsylvania have opted to use NHSN as their
primary system for mandated reporting. Reporting compliance is
completed by healthcare facilities in their respective jurisdictions,
with emphasis on those states and municipalities acquiring varying
consequences for failure to use NHSN. Additionally, healthcare
facilities in five U.S. territories (Puerto Rico, American Samoa, the
U.S. Virgin Islands, Guam, and the Northern Mariana Islands) are
voluntarily reporting to NHSN. Additional territories are projected to
follow with similar use of NHSN for reporting purposes. NHSN's data is
used to aid in the tracking of HAIs and guide infection prevention
activities/practices that protect patients. The Centers for Medicare
and Medicaid Services (CMS)and other payers use these data to determine
incentives for performance at healthcare facilities across the US and
surrounding territories, and members of the public may use some
protected data to inform their selection among available providers.
Each of these parties is dependent on the completeness and accuracy of
the data. CDC and CMS work closely and are fully committed to ensuring
complete and accurate reporting, which are critical for protecting
patients and guiding national, state, and local prevention priorities.
CMS collects some HAI data and healthcare personnel influenza
vaccination summary data, which is done on a voluntary basis as part of
its Fee-for-Service Medicare quality reporting programs, while others
may report data required by a federal mandate. Facilities that fail to
report quality measure data are subject to partial payment reduction in
the applicable Medicare Fee-for-Service payment system. CMS links their
quality reporting to payment for Medicare-eligible acute care
hospitals, inpatient rehabilitation facilities, long-term acute care
facilities, oncology hospitals, inpatient psychiatric facilities,
dialysis facilities, and ambulatory surgery centers. Facilities report
HAI data and healthcare personnel influenza vaccination summary data to
CMS via NHSN as part of CMS's quality reporting programs to
[[Page 78970]]
receive full payment. Still, many healthcare facilities, even in states
without HAI reporting legislation, submit limited HAI data to NHSN
voluntarily. NHSN's data collection updates continue to support the
incentive programs managed by CMS. For example, survey questions
support requirements for CMS' quality reporting programs. Additionally,
CDC has collaborated with CMS on a voluntary National Nursing Home
Quality Collaborative, which focuses on recruiting nursing homes to
report HAI data to NHSN and to retain their continued participation.
The NHSN collection was previously approved in January of 2022 for
1,321,991 burden hours. The proposed changes to NHSN include revisions
to 41 existing data collection forms. CDC requests OMB approval for an
estimated 1,614,651 annual burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average
Number of responses per burden per
Type of respondent Form No. & name respondents respondent response (in
(in hours) hours)
----------------------------------------------------------------------------------------------------------------
NHSN Participant.................... 57.100 NHSN Registration 2,000 1 5/60
Form.
57.101 Facility Contact 2,000 1 10/60
Information.
57.103 Patient Safety 6765 1 90/60
Component--Annual
Hospital Survey.
57.104 Facility 800 1 5/60
Administrator Change
Request Form.
57.105 Group Contact 1,000 1 5/60
Information.
57.106 Patient Safety 7,821 12 15/60
Monthly Reporting Plan.
57.108 Primary Bloodstream 5,775 5 38/60
Infection (BSI).
57.111 Pneumonia (PNEU)... 1,800 2 30/60
57.112 Ventilator- 5,463 8 28/60
Associated Event.
57.113 Pediatric 334 1 30/60
Ventilator-Associated
Event (PedVAE).
57.114 Urinary Tract 6,000 5 20/60
Infection (UTI).
57.115 Custom Event....... 600 91 35/60
57.116 Denominators for 1,100 12 4/60
Neonatal Intensive Care
Unit (NICU).
57.117 Denominators for 500 12 5/60
Specialty Care Area (SCA)/
Oncology (ONC).
57.118 Denominators for 5,500 60 5/60
Intensive Care Unit (ICU)/
Other locations (not NICU
or SCA).
57.120 Surgical Site 6,000 9 35/60
Infection (SSI).
57.121 Denominator for 6,000 602 10/60
Procedure.
57.122 HAI Progress Report 55 1 28/60
State Health Department
Survey.
57.123 Antimicrobial Use 2,500 12 5/60
and Resistance (AUR)-
Microbiology Data
Electronic Upload
Specification Tables.
57.124 Antimicrobial Use 2,500 12 5/60
and Resistance (AUR)-
Pharmacy Data Electronic
Upload Specification
Tables.
57.125 Central Line 500 213 25/60
Insertion Practices
Adherence Monitoring.
57.126 MDRO or CDI 720 11 30/60
Infection Form.
57.127 MDRO and CDI 5,500 29 15/60
Prevention Process and
Outcome Measures Monthly
Monitoring.
57.128 Laboratory- 4,800 79 20/60
identified MDRO or CDI
Event.
57.129 Adult Sepsis....... 50 250 25/60
57.135 Late Onset Sepsis/ 300 6 5/60
Meningitis Denominator
Form: Data Table for
monthly electronic upload.
57.136 Late Onset Sepsis/ 300 6 5/60
Meningitis Event Form:
Data Table for Monthly
Electronic Upload.
57.137 Long-Term Care 17,700 1 120/60
Facility Component--
Annual Facility Survey.
57.138 Laboratory- 1998 24 20/60
identified MDRO or CDI
Event for LTCF.
57.139 MDRO and CDI 1998 12 20/60
Prevention Process
Measures Monthly
Monitoring for LTCF.
57.140 Urinary Tract 339 36 35/60
Infection (UTI) for LTCF.
57.141 Monthly Reporting 2011 12 5/60
Plan for LTCF.
57.142 Denominators for 339 12 35/60
LTCF Locations.
57.143 Prevention Process 130 12 5/60
Measures Monthly
Monitoring for LTCF.
57.150 LTAC Annual Survey. 620 1 82/60
57.151 Rehab Annual Survey 1,340 1 82/60
57.200 Healthcare 50 1 480/60
Personnel Safety
Component Annual Facility
Survey.
57.204 Healthcare Worker 50 200 20/60
Demographic Data.
57.205 Exposure to Blood/ 50 50 60/60
Body Fluids.
57.206 Healthcare Worker 50 30 15/60
Prophylaxis/Treatment.
57.207 Follow-Up 50 50 15/60
Laboratory Testing.
57.210 Healthcare Worker 50 50 10/60
Prophylaxis/Treatment-
Influenza.
57.300 Hemovigilance 500 1 85/60
Module Annual Survey.
57.301 Hemovigilance 500 12 60/60
Module Monthly Reporting
Plan.
57.303 Hemovigilance 500 12 70/60
Module Monthly Reporting
Denominators.
57.305 Hemovigilance 500 10 10/60
Incident.
57.306 Hemovigilance 500 1 35/60
Module Annual Survey--Non-
acute care facility.
57.307 Hemovigilance 500 4 20/60
Adverse Reaction--Acute
Hemolytic Transfusion
Reaction.
57.308 Hemovigilance 500 4 20/60
Adverse Reaction--
Allergic Transfusion
Reaction.
[[Page 78971]]
57.309 Hemovigilance 500 1 20/60
Adverse Reaction--Delayed
Hemolytic Transfusion
Reaction.
57.310 Hemovigilance 500 2 20/60
Adverse Reaction--Delayed
Serologic Transfusion
Reaction.
57.311 Hemovigilance 500 4 20/60
Adverse Reaction--Febrile
Non-hemolytic Transfusion
Reaction.
57.312 Hemovigilance 500 1 20/60
Adverse Reaction--
Hypotensive Transfusion
Reaction.
57.313 Hemovigilance 500 1 20/60
Adverse Reaction--
Infection.
57.314 Hemovigilance 500 1 20/60
Adverse Reaction--Post
Transfusion Purpura.
57.315 Hemovigilance 500 1 20/60
Adverse Reaction--
Transfusion Associated
Dyspnea.
57.316 Hemovigilance 500 1 20/60
Adverse Reaction--
Transfusion Associated
Graft vs. Host Disease.
57.317 Hemovigilance 500 1 20/60
Adverse Reaction--
Transfusion Related Acute
Lung Injury.
57.318 Hemovigilance 500 2 20/60
Adverse Reaction--
Transfusion Associated
Circulatory Overload.
57.319 Hemovigilance 500 1 20/60
Adverse Reaction--Unknown
Transfusion Reaction.
57.320 Hemovigilance 500 1 20/60
Adverse Reaction--Other
Transfusion Reaction.
57.400 Outpatient 700 1 10/60
Procedure Component--
Annual Facility Survey.
57.401 Outpatient 700 12 15/60
Procedure Component--
Monthly Reporting Plan.
57.402 Outpatient 200 1 40/60
Procedure Component Same
Day Outcome Measures.
57.403 Outpatient 200 400 40/60
Procedure Component--
Monthly Denominators for
Same Day Outcome Measures.
57.404 Outpatient 700 100 40/60
Procedure Component--SSI
Denominator.
57.405 Outpatient 700 5 40/60
Procedure Component--
Surgical Site (SSI) Event.
57.500 Outpatient Dialysis 7,200 1 12/60
Center Practices Survey.
57.501 Dialysis Monthly 7,200 12 5/60
Reporting Plan.
57.502 Dialysis Event..... 7,200 30 25/60
57.503 Denominator for 7,200 30 10/60
Outpatient Dialysis.
57.504 Prevention Process 1,730 12 75/60
Measures Monthly
Monitoring for Dialysis.
57.505 Dialysis Patient 615 50 10/60
Influenza Vaccination.
57.506 Dialysis Patient 615 5 10/60
Influenza Vaccination
Denominator.
57.507 Home Dialysis 430 1 30/60
Center Practices Survey.
Weekly Healthcare 125 52 60/60
Personnel Influenza
Vaccination Cumulative
Summary for Non-Long-Term
Care Facilities.
Weekly Healthcare 1,200 52 60/60
Personnel Influenza
Vaccination Cumulative
Summary for Long-Term
Care Facilities.
Weekly Resident Influenza 2,500 52 60/60
Vaccination Cumulative
Summary for Long-Term
Care Facilities.
Annual Healthcare 5,000 1 120/60
Personnel Influenza
Vaccination Summary.
Monthly Survey Patient 2,500 12 60/60
Days & Nurse Staffing.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-28004 Filed 12-22-22; 8:45 am]
BILLING CODE 4163-18-P
